Scripps Research Institute is planning to construct a new 147,000-sf laboratory complex in La Jolla, Calif. Supporting the consolidation of research space to promote interaction and collaboration, the project will provide a 12,000-sf NMR suite and advanced laboratories for the study of immunology, structural biology, neuroscience, and global health. Occupancy is expected in 2019.
The U.S. Department of Agriculture has selected Merrick & Company to develop the Program of Requirements (POR) for the renovation of the Southeast Poultry Research Laboratory (SEPRL) in Athens, Ga. The $158 million modernization project includes new construction and renovation of existing facilities on an active, 60-year-old campus that encompasses biosafety laboratories, brooding and breeding facilities, administrative offices, and support space.
The Army Institute of Public Health has awarded a $206 million contract to a joint venture of The Walsh Group and Gilbane Building Company for the Public Health Command (PHC) laboratory replacement project. Located on 20 acres at Aberdeen Proving Ground in Maryland, the 275,000-sf biomedical research facility will include wet labs, field labs, offices, anechoic chambers, laser labs, a vivarium, an insectary, and a 43,000-gsf central utility plant.
The Jackson Laboratory (JAX) is partnering with the University of Connecticut to create the $7.7 million Single Cell Genomics Center in Farmington. The facility will be located in JAX’s Genomic Medicine facility on the UConn Health campus. JAX is also planning to develop the Center for Precision Genetics at the site, supported by a $10 million grant from the National Institutes of Health.
Specialized biomedical core facilities accelerate scientific research and make the most of funding resources, but it takes considerable expertise in both technology and business to attain these results. To ensure the centralized model provides the most productive and cost-effective support to researchers, University Health Network (UHN) in Toronto has assembled a toolkit of proven strategies and operating principles. The foremost requirements are a robust knowledge base in science and technology and a strong business orientation.
Biopharmaceutical firm Baxalta is developing a 200,000-sf research and development center in Cambridge, Mass. Located at Kendall Square, the leased facility will support the commercialization of preclinical discoveries made in partnership with academic institutions and independent biotech firms. The project is expected to house approximately 500 employees upon completion in late 2015. Baxalta is a subsidiary of Baxter International, based in Deerfield, Ill.
Lancer Sales USA introduced a new line of laboratory steam sterilizers in August of 2015. Developed for the high performance sterilization of labware, processed materials, and research byproducts, the sterilizers can be installed in newly constructed laboratories or in existing facilities. The units are available in single and double door pass-through configurations with four cabinet sizes, and all models stand 74” high with vanishing vertical doors that eliminate the need for elevation clearance.
Texas A&M University opened an 11,000-sf avian health complex for the College of Veterinary Medicine & Biomedical Sciences in August of 2015. Located in College Station, the climate-controlled aviary facility provides a BSL-2 biocontainment lab, a bird hospital, quarantine suites, three isolation rooms, classrooms, and offices.
The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) is constructing a 950,000-sf replacement facility at Fort Detrick, Md. The $800 million project will provide BSL-2, BSL-3, and BSL-4 laboratory space to support advanced biomedical research. The U.S. Army Corps of Engineers began construction on the project in August of 2009 and completion is expected in 2017.
SUNY Upstate Medical Center began construction in June of 2015 on the second phase of the Central New York Biotech Accelerator (CNYBAC) in Syracuse, N.Y. Designed by The S/L/A/M Collaborative, the project includes the build out of the second and third floors of the facility to house the Upstate Medical Innovation and Novel Discovery Center (MIND) and the Molecular Pathology Next Generation Sequencing Lab.
In an era of shrinking research funding and growing reliance on complex technologies, a centralized core model resolves a host of issues faced by sizable institutions like University Health Network (UHN) in Toronto, Canada’s largest research hospital.
The University of Maryland is building a state-of-the-art engineering teaching and research building for the era of convergence science. It is designed to facilitate the practical integration of bioscience, medicine, and engineering to develop new biomedical devices and other health-related advancements. When it opens in 2017, the six-floor, 184,000-sf A. James Clark Hall will serve as a national center for innovation that combines engineering with biology, medicine, and information technology in support of private and government partnerships.
Frontage Labs opened a 36,000-sf clinical research center in Secaucus in July of 2015. Designed by DMR Architects, the facility provides a biomedical laboratory, 160 observation beds, exam rooms, administrative offices, dining facilities, a recreation center, and a pharmacy. The project was developed by retrofitting an existing building to meet the specifications of Frontage Labs, an early-stage drug development company based in Exton, Pa.
llumina is partnering with BioMed Realty Trust to develop a 155,000-sf research center in Cambridge in the United Kingdom. Supporting the creation of advanced biopharmaceutical and bioinformatics technologies, the leased facility is designed for ease of expansion, enabling the project to grow by 70,000 sf to provide a total of 225,000 sf of collaborative lab and office space. Illumina is headquartered in San Diego.
Bristol-Myers Squibb will begin construction in July of 2015 on a new research and development facility in Cambridge, Mass. Providing collaborative laboratories and offices for the creation of advanced biomedical and pharmaceutical products, the sustainably designed project comprises 208,000 sf of leased space in the Alexandria Center at Kendall Square development. Completion is expected in late 2017.
